SRPT - Sarepta Therapeutics, Inc. News

Discover

SRPT

Sarepta Therapeutics, Inc.

20.11

2 x 14.65

2 x 25.24

bid

ask

-

0.56

2.71%

2 @ 04:00 PM

20.02 -0.09 (0.45%)

Ytd	-6.55%
1y	8.59%

19.62

day range

20.65

14.68

52 week range

25.32

Open	20.63	Prev Close	20.67	Low	19.62	High	20.65	Mkt Cap	2.12B
Vol	6.29M	Avg Vol	3.40M	EPS	-1.57	P/E	N/A	Forward P/E	7.64
Beta	0.26	Short Ratio	8.16	Inst. Own	103.80%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	11-04	50-d Avg	18.55	200-d Avg	19.27	1yr Est	21.86

SRPT News

Squarepoint Ops LLC Has $1.51 Million Stock Position in Sarepta Therapeutics, Inc. $SRPT

defenseworld.net

Squarepoint Ops LLC Has $1.51 Million Stock Position in Sarepta Therapeutics, Inc. $SRPT

Squarepoint Ops LLC cut its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 36.5%

Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near

Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near

Sarepta Therapeutics NASDAQ: SRPT outlined plans to stabilize demand for its ELEVIDYS gene therapy w

Sarepta Therapeutics, Inc. (SRPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

seekingalpha.com

Sarepta Therapeutics, Inc. (SRPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conferenc

Sarepta Therapeutics, Inc. (SRPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conferenc

Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday

Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving

U.S. stocks fell, but Caleres surged 14% on strong results and higher guidance. Opus Genetics, Signe

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics shares react to Novartis Phase 3 trial results in DM1 while Sarepta progresses

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endp

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while

10 Health Care Stocks With Whale Alerts In Today’s Session

10 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w